(Q33329495)

English

Phase II study of docetaxel in patients with metastatic pancreatic cancer: a Japanese cooperative study. Cooperative Group of Docetaxel for Pancreatic Cancer in Japan

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 July 2017

Phase II study of docetaxel in patients with metastatic pancreatic cancer: a Japanese cooperative study. Cooperative Group of Docetaxel for Pancreatic Cancer in Japan (English)

1 reference

Europe PubMed Central

25 July 2017

pancreatic cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

S Okada

1

1 reference

Europe PubMed Central

25 July 2017

Y Sakata

2

1 reference

Europe PubMed Central

25 July 2017

S Matsuno

3

1 reference

Europe PubMed Central

25 July 2017

M Kurihara

4

1 reference

Europe PubMed Central

25 July 2017

Y Sasaki

5

1 reference

Europe PubMed Central

25 July 2017

Y Ohashi

6

1 reference

Europe PubMed Central

25 July 2017

T Taguchi

7

1 reference

Europe PubMed Central

25 July 2017

language of work or name

0 references

publication date

1 May 1999

1 reference

Europe PubMed Central

25 July 2017

British Journal of Cancer

1 reference

Europe PubMed Central

25 July 2017

80

1 reference

Europe PubMed Central

25 July 2017

438-443

1 reference

Europe PubMed Central

25 July 2017

3-4

1 reference

Europe PubMed Central

25 July 2017

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6690375

0 references

A multicentre phase II study of docetaxel 75 mg m-2 as first-line chemotherapy for patients with advanced breast cancer: report of the Clinical Screening Group of the EORTC. European Organization for Research and Treatment of Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362341

21 June 2018

A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362341

21 June 2018

Taxol and taxotere--current status and future prospects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362341

21 June 2018

Phase II trial of docetaxel in patients with platinum-refractory advanced ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362341

21 June 2018

Phase I clinical trial of RP 56976 (docetaxel) a new anticancer drug

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362341

21 June 2018

Docetaxel (Taxotere) is active in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group (ECTG)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362341

21 June 2018

Paclitaxel (taxol)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362341

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362341

21 June 2018

Reporting results of cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362341

21 June 2018

Optimal two-stage designs for phase II clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362341

21 June 2018

Relationships between the structure of taxol analogs and their antimitotic activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362341

21 June 2018

Promotion of microtubule assembly in vitro by taxol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362341

21 June 2018

Docetaxel: current status and future prospects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362341

31 October 2018

One-sample multiple testing procedure for phase II clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/10408850

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/10408850

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: a Japanese cooperative study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10408850

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6690375

1 reference

Europe PubMed Central

25 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

25 July 2017

1 reference

Europe PubMed Central

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33329495&oldid=1873411430"